Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Other ETFs median (19 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 22 May 2026 – 20 Aug 2026, limited by SBI Nifty Smallcap 250 ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | SBI Nifty Smallcap 250 ETF | Nifty Smallcap 250 |
|---|---|---|
| 22 May 2026 | ₹100.00 | ₹100.00 |
| 30 May 2026 | ₹101.29 | ₹101.29 |
| 06 Jun 2026 | ₹101.66 | ₹101.66 |
| 14 Jun 2026 | ₹101.83 | ₹101.81 |
| 21 Jun 2026 | ₹105.61 | ₹105.59 |
| 29 Jun 2026 | ₹105.05 | ₹105.03 |
| 06 Jul 2026 | ₹107.79 | ₹107.77 |
| 14 Jul 2026 | ₹107.20 | ₹107.15 |
| 21 Jul 2026 | ₹107.99 | ₹107.90 |
| 29 Jul 2026 | ₹107.29 | ₹107.17 |
| 05 Aug 2026 | ₹109.38 | ₹109.22 |
| 13 Aug 2026 | ₹109.68 | ₹109.48 |
| 20 Aug 2026 | ₹109.54 | ₹109.32 |
| Metric | SBI · Regular · IDCW NAV ₹18.36 Very High risk Unrated | Category median Other ETFs · 19 funds |
|---|---|---|
| — | +0.77% | |
| — | +9.55% | |
| — | +9.21% | |
| — | +11.55% | |
| +9.54% | +10.84% | |
| +23.86% | — | |
| — | +13.03% | |
| — | +13.13% | |
| — | +12.79% | |
| Risk | ||
| 13.55% | 13.68% | |
| — | 0.22 | |
| — | 0.31 | |
| -3.06% | -21.96% | |
| Nifty Smallcap 250 | — | |
| — | +0.04% | |
| — | 0.99 | |
| — | 99.9% | |
| — | 95.5% | |
| 0.91% | 0.25% | |
| ₹3.00Cr | ₹77.96Cr | |
| None | — | |
| None | — | |
| — | — | |
| ₹5.00K | — | |
| — | — | |
| Viral Chhadva | — | |
| 22 May 2026 | — | |
| 250 | — | |
| 12.1% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.